Anthropic Inc. made its trading debut on the Nasdaq this past Thursday, opening its shares at US$8 each. While it may be too late for retail investors to participate directly in the initial public offering, the event has prompted the introduction of a range of Canadian investment products designed to give domestic investors exposure to the artificial intelligence company.
Among the new offerings are Canadian-listed Anthropic-focused exchange-traded funds (ETFs) and Canadian Depositary Receipts (CDRs). These products provide alternatives to purchasing Anthropic shares on the Nasdaq and allow investors to trade in Canadian dollars. The CDRs, which will be listed on the Toronto Stock Exchange under the ticker ANTH, initially represent one-quarter of an Anthropic Nasdaq share. The ratio is subject to adjustment based on fluctuations in the Canadian-U.S. dollar exchange rate. Issuers like CIBC and Bank of Montreal incorporate a currency hedging fee into these instruments, intended to reduce the foreign exchange risk for Canadian investors, though the hedge may also limit potential gains if the Canadian dollar weakens.
In addition to straightforward share exposure through CDRs, more complex ETFs employing leverage and covered-call strategies have been launched. For example, the Harvest Anthropic Enhanced High Income Shares ETF (ANTE) applies 25 percent leverage and sells options on up to half of its holdings to generate monthly income. This approach builds on the success of similar Space Exploration Technologies Corp. (SpaceX) ETFs in Canada, which have attracted significant investor interest since their launch earlier this year. Purpose Investments Inc., Ninepoint Partners LP, and LongPoint ETFs have also announced or introduced Anthropic-related products, including some offering up to 200 percent leverage, with varying option strategies.
Executives from issuing firms emphasize that these products respond to strong demand from Canadian investors seeking exposure to high-growth global companies without direct transactions in U.S. currency. Elliot Scherer, head of Wealth Solutions at CIBC Capital Markets, highlighted that the SpaceX CDR has amassed over US$500 million in assets since its introduction in June, underscoring investor appetite. However, he noted investors have the option to purchase shares directly in U.S. dollars if preferred.
Financial advisors and market analysts caution about the risks inherent in these investment vehicles. Leveraged ETFs can magnify both gains and losses, and covered-call strategies cap upside potential on the covered portion of the portfolio. Moreover, these ETFs are newly listed with limited operating histories, adding an additional layer of uncertainty. Jason Heath, managing director at Objective Financial Partners, underscored that investor enthusiasm should be tempered with caution, reminding that a company’s operational success does not necessarily translate into stock market gains. He advised investors to avoid overconcentration in any individual stock or product, including Anthropic.
Overall, the Anthropic IPO has expanded the landscape of AI-related investment opportunities for Canadian investors, offering a range of products varying in complexity and risk. While these options provide access to emerging technology firms, investors are urged to carefully consider the associated trade-offs and their own risk tolerance when participating.
